Boston Scientific Corp.
BSXBoston Scientific Corporation (BSX) is a global medical device company specializing in innovative healthcare solutions. Founded in 1979, it develops and manufactures devices for cardiovascular, respiratory, digestive, and other medical conditions, focusing on minimally invasive procedures and improving patient outcomes.
Company News
The global internal neuromodulation devices market is projected to grow from $11.81 billion in 2024 to $44.57 billion by 2033, driven by AI-powered personalized therapies, miniaturization, and increasing demand for non-opioid pain management solutions.
Boston Scientific reported strong Q3 2025 financial results, with revenues of $5.07 billion and adjusted earnings of 75 cents per share, exceeding analyst expectations. The company forecasts robust net sales growth and continues to see strong performance in key product lines like WATCHMAN.
The article explores three healthcare stocks leveraging artificial intelligence to improve efficiency, patient outcomes, and administrative processes in the medical sector, highlighting how AI is transforming healthcare delivery.
Baxter International Inc. reported better-than-expected Q2 2024 earnings, with adjusted EPS of 68 cents beating the consensus estimate. Revenue also topped expectations, driven by growth across the company's business segments. The company provided positive guidance for Q3 and full-year 2024.
The company is planning to file for regulatory approval of a label expansion for Ozempic in the U.S. and European Union in 2024.
